Suppr超能文献

药物对微管动力学的调节作用:细胞调节因子作用的范例

Modulation of microtubule dynamics by drugs: a paradigm for the actions of cellular regulators.

作者信息

Wilson L, Panda D, Jordan M A

机构信息

Department of Molecular, Cellular, and Developmental Biology, University of California, Santa Barbara, CA 93106, USA.

出版信息

Cell Struct Funct. 1999 Oct;24(5):329-35. doi: 10.1247/csf.24.329.

Abstract

Microtubules are intrinsically dynamic polymers. Two kinds of dynamic behaviors, dynamic instability and treadmilling, are important for microtubule function in cells. Both dynamic behaviors appear to be tightly regulated, but the cellular molecules and the mechanisms responsible for the regulation remain largely unexplored. While microtubule dynamics can be modulated transiently by the interaction of regulatory molecules with soluble tubulin, the microtubule itself is likely to be the primary target of cellular molecules that regulate microtubule dynamics. The antimitotic drugs that modulate microtubule dynamics serve as excellent models for such cellular molecules. Our laboratory has been investigating the interactions of small drug molecules and stabilizing microtubule-associated proteins (MAPs) with microtubule surfaces and ends. We find that drugs such as colchicine, vinblastine, and taxol, and stabilizing MAPs such as tau, strongly modulate microtubule dynamics at extremely low concentrations under conditions in which the microtubule polymer mass is minimally affected. The powerful modulation of the dynamics is brought about by the binding of only a few drug or MAP molecules to distinct binding sites at the microtubule surface or end. Based upon our understanding of the well-studied drugs and stabilizing MAPs, it is clear that molecules that regulate dynamics such as Kin 1 and stathmin could bind to a large number of distinct tubulin sites on microtubules and employ an array of mechanisms to selectively and powerfully regulate microtubule dynamics and dynamics-dependent cellular functions.

摘要

微管是具有内在动力学特性的聚合物。动态不稳定性和踏车行为这两种动力学行为对于细胞中的微管功能至关重要。这两种动力学行为似乎都受到严格调控,但负责调控的细胞分子和机制在很大程度上仍未得到充分探索。虽然微管动力学可通过调控分子与可溶性微管蛋白的相互作用而被短暂调节,但微管本身可能是调控微管动力学的细胞分子的主要作用靶点。调节微管动力学的抗有丝分裂药物可作为此类细胞分子的优秀模型。我们实验室一直在研究小药物分子和稳定微管相关蛋白(MAPs)与微管表面及末端的相互作用。我们发现,诸如秋水仙碱、长春碱和紫杉醇等药物,以及诸如tau蛋白等稳定微管相关蛋白,在微管聚合物质量受影响最小的条件下,能在极低浓度下强烈调节微管动力学。仅少数药物或微管相关蛋白分子与微管表面或末端的不同结合位点结合,就能实现对动力学的强大调节。基于我们对已深入研究的药物和稳定微管相关蛋白的了解,很明显,诸如Kin 1和stathmin等调节动力学的分子可能会与微管上大量不同的微管蛋白位点结合,并采用一系列机制来选择性且有力地调节微管动力学及依赖于动力学的细胞功能。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验